Dendroaspis natriuretic peptide in hepatic cirrhosis. 2001

E Fábrega, and J Crespo, and M Rivero, and F Casafont, and B Castro, and M T García-Unzueta, and J A Amado, and F Pons-Romero
Gastroenterology and Hepatology Unit, University Hospital Marquis de Valdecilla, Santander, Spain.

OBJECTIVE Dendroaspis natriuretic peptide (DNP) is a novel peptide that is structurally similar to atrial, brain, and C-type natriuretic peptides. Many natriuretic peptides are increased in hepatic cirrhosis, but the role of DNP in cirrhosis is unknown at present. The aim of the study was to investigate plasma levels of dendroaspis natriuretic-like immunoreactivity in cirrhosis. METHODS We measured plasma concentrations of DNP by radioimmunoassay methods in 12 cirrhotic patients without ascites and 44 cirrhotic patients with ascites, and compared these values with 20 age-matched healthy subjects. Renal function, plasma cGMP concentration, plasma renin activity, and plasma endothelin concentration were measured in each patient. RESULTS Patients without ascites had circulating levels of DNP similar to those of healthy subjects. By contrast, patients with ascites had increased circulating DNP levels compared to both patients without ascites and healthy subjects. In addition, circulating levels of DNP increased in relation to the severity of cirrhosis. Significant positive correlations were also found between DNP levels, endothelin concentrations, and plasma renin activity. CONCLUSIONS The results of this study indicate that plasma DNP is increased in cirrhotic patients with ascites.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D004546 Elapid Venoms Venoms from snakes of the family Elapidae, including cobras, kraits, mambas, coral, tiger, and Australian snakes. The venoms contain polypeptide toxins of various kinds, cytolytic, hemolytic, and neurotoxic factors, but fewer enzymes than viper or crotalid venoms. Many of the toxins have been characterized. Cobra Venoms,Elapidae Venom,Elapidae Venoms,Naja Venoms,Cobra Venom,Elapid Venom,Hydrophid Venom,Hydrophid Venoms,King Cobra Venom,Naja Venom,Ophiophagus hannah Venom,Sea Snake Venom,Sea Snake Venoms,Venom, Cobra,Venom, Elapid,Venom, Elapidae,Venom, Hydrophid,Venom, King Cobra,Venom, Naja,Venom, Ophiophagus hannah,Venom, Sea Snake,Venoms, Cobra,Venoms, Elapid,Venoms, Elapidae,Venoms, Hydrophid,Venoms, Naja,Venoms, Sea Snake
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

E Fábrega, and J Crespo, and M Rivero, and F Casafont, and B Castro, and M T García-Unzueta, and J A Amado, and F Pons-Romero
June 2007, Biochemical and biophysical research communications,
E Fábrega, and J Crespo, and M Rivero, and F Casafont, and B Castro, and M T García-Unzueta, and J A Amado, and F Pons-Romero
January 2002, Lancet (London, England),
E Fábrega, and J Crespo, and M Rivero, and F Casafont, and B Castro, and M T García-Unzueta, and J A Amado, and F Pons-Romero
August 1999, Kidney international,
E Fábrega, and J Crespo, and M Rivero, and F Casafont, and B Castro, and M T García-Unzueta, and J A Amado, and F Pons-Romero
January 2012, Peptides,
E Fábrega, and J Crespo, and M Rivero, and F Casafont, and B Castro, and M T García-Unzueta, and J A Amado, and F Pons-Romero
October 2002, Nephron,
E Fábrega, and J Crespo, and M Rivero, and F Casafont, and B Castro, and M T García-Unzueta, and J A Amado, and F Pons-Romero
January 1990, Gastroenterologisches Journal : Organ der Gesellschaft fur Gastroenterologie der DDR,
E Fábrega, and J Crespo, and M Rivero, and F Casafont, and B Castro, and M T García-Unzueta, and J A Amado, and F Pons-Romero
March 2002, Clinical and experimental pharmacology & physiology,
E Fábrega, and J Crespo, and M Rivero, and F Casafont, and B Castro, and M T García-Unzueta, and J A Amado, and F Pons-Romero
January 2006, Regulatory peptides,
E Fábrega, and J Crespo, and M Rivero, and F Casafont, and B Castro, and M T García-Unzueta, and J A Amado, and F Pons-Romero
August 2002, Cardiovascular research,
E Fábrega, and J Crespo, and M Rivero, and F Casafont, and B Castro, and M T García-Unzueta, and J A Amado, and F Pons-Romero
January 2014, Turkish neurosurgery,
Copied contents to your clipboard!